Amneal Pharmaceuticals, Inc.AMRX
Close of Friday, October 23, 2026 · Amneal Pharmaceuticals, Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$20.38
vs its Pivot
+31.2%
OnlyAlpha Score
50
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +2.9% | +61.8% | +95.4% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
Suppliers, customers and partners
AMRX sells to
| Cencora | top-4 customers; ~71% of net revenue combined |
| McKesson | top-4 customers; ~71% of net revenue combined |
| Cardinal Health | top-4 customers; ~71% of net revenue combined |
| CVS Health | top-4 customers; ~71% of net revenue combined |
From the companies' own annual reports filed with the SEC.
Get AMRX in your free daily emailAfter every close: whether AMRX is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track AMRX free → Full Stock check
Track AMRX free → Full Stock check